Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Alistair Howitt a Warders
Medical Centre, Tonbridge, Kent TN9 1LA, b Department of General
Practice, Guy's, King's And St Thomas' School of Medicine,
London SE11 6SP
Correspondence to: Dr Howitt
ajhowitt{at}warders.co.uk
Objective:
To determine the extent to which
implementation of an evidence based treatment, antithrombotic treatment
in atrial fibrillation, is possible in general practice.
Design:
Audit and qualitative study of patients with atrial fibrillation and an educational intervention for patients judged
eligible for antithrombotic treatment.
Setting:
South east England.
Subjects:
56 patients with a history of atrial fibrillation.
Interventions:
Assessment and interview to ascertain
patients' views on antithrombotic treatment.
Main outcome measures:
Number of patients receiving
antithrombotic treatment.
Results:
Out of 13 239 patients, 132 had a history of
atrial fibrillation of which 100 were at risk of thromboembolism. After
the study, 52 patients were taking warfarin. Of the remaining 48 patients (of whom 41 were taking aspirin), eight were too ill to
participate, 16 were unable to consent, four refused the interview, and
20 declined warfarin. Patients declining warfarin were inclined to seek
a higher level of benefit than those taking it, as measured by the
minimal clinically important difference. Qualitative data obtained
during the interviews suggested that patients' health beliefs were
important factors in determining their choice of treatment.
Conclusion:
Patients' unwillingness to take warfarin
seemed to be a major factor in limiting the number who would eventually take it.
Key messages
Read all Rapid Responses